lenalidomide has been researched along with Acute Lymphoid Leukemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Abba, M; Gajkowska-Kulik, J; Sadowska-Klasa, A; Zaucha, JM | 1 |
| Böttcher, S; Brüggemann, M; Coscia, M; Crespo, M; de la Serna, J; Eckert, R; Eichhorst, B; Fink, AM; Fischer, K; Fürstenau, M; Hallek, M; Herling, CD; Ritgen, M; Robrecht, S; Schilhabel, A; Stilgenbauer, S; Tausch, E; Vitale, C; Weiss, J; Weppner, G | 1 |
| Deng, L; Du, J; Liang, D; Wang, L; Wei, C; Yang, J; Zhang, X; Zheng, Y | 1 |
| Burgos, S; Fuente, L; Garcia-Manero, G; Jabbour, EJ; Kanagal-Shamanna, R; Mela-Osorio, MJ; Montalban-Bravo, G; Soltysiak, KA | 1 |
| Blum, KA; Blum, W; Byrd, JC; Foster, DJR; Gao, Y; Grever, MR; Hofmeister, CC; Hughes, JH; Marcucci, G; Phelps, MA; Reuter, SE; Upton, RN | 1 |
| García-Muñoz, R; Muñoz-Rodríguez, A; Rabasa, P; Robles-de-Castro, D | 1 |
| Chen, L; Gonzalez, MM; Kidd, L; Nguyen, N; Quesada, J | 1 |
| Agostino, NM; Gheith, S; Nair, R; Popescu, D | 1 |
| Fong, R; Lo, M; Tan, M; Young, R | 1 |
| Bourmaud, A; Cahn, JY; Cornillon, J; Guyotat, D; Molucon-Chabrot, C; Tavernier-Tardy, E; Thomas, X; Tinquaut, F | 1 |
| Becker, H; Blum, W; Byrd, JC; Chandler, JC; Curfman, J; Devine, SM; Garzon, R; Grever, MR; Kefauver, C; Klisovic, RB; Liu, S; Marcucci, G; Mickle, J; Phelps, MA; Rozewski, DM; Schaaf, L; Walker, A; Whitman, SP; Yang, X | 1 |
1 review(s) available for lenalidomide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
Topics: Antineoplastic Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lenalidomide; Maintenance Chemotherapy; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thalidomide; Transplantation, Autologous | 2013 |
3 trial(s) available for lenalidomide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.
Topics: B-Lymphocytes; Female; Humans; Immunologic Factors; Incidence; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2021 |
A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Lenalidomide; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Survival Analysis; Thalidomide | 2017 |
Dose escalation of lenalidomide in relapsed or refractory acute leukemias.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sialic Acid Binding Ig-like Lectin 3; Thalidomide | 2010 |
7 other study(ies) available for lenalidomide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma - diagnostic and therapeutic dilemma.
Topics: Humans; Lenalidomide; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2022 |
Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation.
Topics: Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2021 |
Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report.
Topics: Aged; Anemia; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; B-Lymphocytes; Bone Marrow; Chromosome Deletion; Cyclophosphamide; Dexamethasone; Disease Progression; Enhancer of Zeste Homolog 2 Protein; Humans; Lenalidomide; Male; Mutation; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytopenia; Treatment Outcome | 2019 |
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
Topics: Administration, Oral; Adult; Aged; B-Lymphocytes; Biological Availability; Clinical Trials, Phase I as Topic; Creatinine; Datasets as Topic; Dose-Response Relationship, Drug; Female; Humans; Immunologic Factors; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Biological; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Elimination; Young Adult | 2019 |
Acute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma.
Topics: Aged; Blood Cell Count; Bone Marrow; Humans; Immunohistochemistry; Lenalidomide; Maintenance Chemotherapy; Male; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Thalidomide | 2013 |
A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide.
Topics: Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Birefringence; Bone Marrow Examination; Fatal Outcome; Female; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Microscopy, Polarization; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Salvage Therapy; Thalidomide; Time Factors; Treatment Outcome | 2014 |
Lenalidomide and secondary acute lymphoblastic leukemia: a case series.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Thalidomide; Treatment Outcome; Young Adult | 2017 |